| Ticker Details |
Laboratory Corporation of America Holdings
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development.
|
| IPO Date: |
May 9, 1995 |
| Sector: |
Healthcare |
| Industry: |
Health Care Providers and Services |
| Market Cap: |
$23.43B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.23 | 0.89%
|
| Avg Daily Range (30 D): |
$3.50 | 1.29%
|
| Avg Daily Range (90 D): |
$3.12 | 1.17%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.88M |
| Avg Daily Volume (30 D): |
.67M |
| Avg Daily Volume (90 D): |
.65M |
| Trade Size |
| Avg Trade Size (Sh.): |
99 |
| Avg Trade Size (Sh.) (30 D): |
26 |
| Avg Trade Size (Sh.) (90 D): |
27 |
| Institutional Trades |
| Total Institutional Trades: |
19,441 |
| Avg Institutional Trade: |
$5.27M |
| Avg Institutional Trade (30 D): |
$22.01M |
| Avg Institutional Trade (90 D): |
$21.24M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$12.93M |
| Avg Closing Trade (30 D): |
$38.79M |
| Avg Closing Trade (90 D): |
$36.85M |
| Avg Closing Volume: |
72.33K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$10.26
|
$3.14
|
$2.85
|
|
Diluted EPS
|
$10.19
|
$3.12
|
$2.84
|
|
Revenue
|
$13.77B
|
$3.56B
|
$3.53B
|
|
Gross Profit
|
$3.92B
|
$1.03B
|
$1.05B
|
|
Net Income / Loss
|
$856.4M
|
$261.5M
|
$238.3M
|
|
Operating Income / Loss
|
$1.33B
|
$396.6M
|
$394.5M
|
|
Cost of Revenue
|
$9.85B
|
$2.54B
|
$2.48B
|
|
Net Cash Flow
|
$-940.5M
|
$-46.3M
|
$259.1M
|
|
PE Ratio
|
28.18
|
|
|
| Splits |
|
Jul 03, 2023
|
1164:1000
|
|
May 13, 2002
|
2:1
|
|
Jun 12, 2001
|
2:1
|
|
May 04, 2000
|
1:10
|
|
|
|
